Fig. 4From: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trialsThe scenario III of same effect for the first three AEs with safety issues (No effect for the rest) under various non-decreasing incidence rate as dosage increases for eight arms. (The dashed line is the expected incidence rate for each AE)Back to article page